30
Participants
Start Date
February 28, 2025
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Autologous Platelet-Rich Plasma (PRP) Injection
Participants will receive autologous PRP injections prepared from their own blood to treat elbow tendinopathy. PRP is a plasma product with a 3-5 times higher platelet concentration than normal blood, containing growth factors such as TGF-β, PDGF, IGF, and EGF, which are known to promote tissue repair and regeneration. The PRP will be injected directly into the affected tendon area to evaluate its clinical effectiveness and the relationship between platelet concentration, growth factors, and treatment outcomes.
Bundang CHA Medical Center, Seongnam-si
CHA University
OTHER